Lundbeck Partnership Brings Brain Health Innovation Expertise to FH21!


We are very pleased to be partnering with Lundbeck, a Danish multinational pharma company, for Frontiers Health 2021, which will take place virtually and in Milan and November 11-12.

Lundbeck has been tirelessly dedicated to brain health innovation for over 70 years, specializing in the treatment of nervous system and psychiatric disorders with the goal of helping every person be at their best, both physically and mentally.

The company’s unwavering commitment to the neuroscience-based global research, development, production, and marketing of therapeutic solutions for those suffering from conditions such as migraines, Alzheimer’s, depression, post-traumatic stress disorder, schizophrenia, Parkinson’s disease, and personality and substance use disorders truly makes a difference for those living with these conditions

Lundbeck’s continued aim of creating partnerships within the medical profession has directly contributed to improving worldwide industry knowledge of nervous system disorders through the discovery and development of new therapeutic strategies targeted at fighting their underlying mechanisms.

Join us at FH21 to learn more and be sure to follow us on our social media channels so you don’t miss other emerging conference details!

Get your pass and stay up-to-date about the 2021 Global Hybrid Conference

MORE STORIES

IF YOU WOULD LIKE TO TAKE PART IN THE EVENT,
OR BE THE FIRST TO FIND OUT ABOUT OUR 2021 EDITION


MORE POSTS